Press Release Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced the presentation of preclinical data on ...

BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster ...

BioAtla (BCAB) announced data in a poster titled, “Phase 2 Trial of Ozuriftamab Vedotin, a Conditionally Binding CAB-ROR2-ADC, in Patients with ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has been ...

J INTS BIO, a company specializing in the development of therapeutics for cancer and rare diseases, officially announced ...

I was in Chicago this weekend attending the ASCO meeting, the largest oncology meeting in the world. Nary a talk or poster ...

RBL LLC, a pioneering biotech venture creation studio dedicated to rapidly building companies based on breakthrough medical technologies from Rice University, today announced the launch of Sentinel ...

The advance promises to improve diabetes research and cell-based ... Researchers Identify a Dual Origin of Cells Controlling Puberty and Reproduction May 21, 2025 — Researchers have shown that ...

Cellular signal boosters use big antennas to improve the coverage in your home or car. These are the top signal boosters for apartments, houses, and vehicles. I’m one of PCMag’s mobile ...

Dr. Alan Bryce presented the preliminary results from a phase II trial of PT-112 monotherapy in late-line metastatic castration-resistant prostate cancer (mCRPC). Late-line mCRPC patients have poor ...

Epstein-Barr virus (EBV), a widespread human ⲩ-herpesvirus, infects nearly 90% of the global population by adulthood. While often asymptomatic in early life, EBV is linked to serious conditions - from ...